Supernus Pharmaceuticals, Inc.
$2.45B- Market cap
- $2.53B
- Debt
- +$43.80M
- Cash
- −$128.45M
Capital structure 98% equity / 2% debt · EV / Revenue 3.40x · EV / EBITDA 50.52x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SUPN · current priceP/S 3.52x
$43.53Latest market snapshot
Implied fair value · at SVC's multiple
$6.7284.6% below market
12.37 SUPN revenue / share×0.54x SVC P/S=$6.72
Market $43.53Implied $6.72
SVC · current priceP/S 0.54x
$7.61Latest market snapshot
Implied fair value · at SUPN's multiple
$49.32548.1% above market
14.01 SVC revenue / share×3.52x SUPN P/S=$49.32
Market $7.61Implied $49.32